Zhongzhi Pharmaceutical Holdings Limited reported no changes to its capital structure for the month ended 31 August 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.

The company’s authorised share capital stayed at 1.56 billion ordinary shares with a par value of HK$0.01 each, representing HK$15.60 million. Issued shares also remained unchanged at 863.60 million, and the company held no treasury shares.

Zhongzhi Pharmaceutical confirmed compliance with the Main Board’s minimum public-float threshold of 25%. The filing shows no share options, warrants, convertibles, or other equity-linked instruments were issued, exercised, or outstanding during the period.

The return was signed by Director Lai Zhi Tian, who affirmed that all regulatory requirements under the Hong Kong Listing Rules were met.